Your browser doesn't support javascript.
loading
Cystic fibrosis year in review 2019: Section 2 pulmonary disease and infections.
Savant, Adrienne P; McColley, Susanna A.
Afiliación
  • Savant AP; Department of Pediatrics, Children's Hospital of New Orleans, New Orleans, Louisiana, USA.
  • McColley SA; Department of Pediatrics, Tulane University, New Orleans, Louisiana, USA.
Pediatr Pulmonol ; 58(3): 672-682, 2023 03.
Article en En | MEDLINE | ID: mdl-32970381
ABSTRACT
During the year 2019, research and case reports or series in the field of cystic fibrosis (CF) were in abundance. To adequately address the large body of CF research published during 2019, the CF year in review will be divided into three sections. This report is the second section, focusing specifically on new research related to pulmonary disease and infections. Additional sections will concentrate on CF transmembrane conductance regulator modulators and the multisystem effects of CF. It is an exciting time to be providing care for patients and their families with CF with all the exciting new discoveries that will be shared in these reviews.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fibrosis Quística Límite: Humans Idioma: En Revista: Pediatr Pulmonol Asunto de la revista: PEDIATRIA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fibrosis Quística Límite: Humans Idioma: En Revista: Pediatr Pulmonol Asunto de la revista: PEDIATRIA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos